1. Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges

   • Deva Priya Sagili Anthony
   • Kavitha Sivakumar
   • Melvin George

   Current Opinion 23 March 2021 Pages: 499 - 509

   

2. Correction to: Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges

   • Deva Priya Sagili Anthony
   • Kavitha Sivakumar
   • Melvin George

   Correction 05 June 2021 Pages: 511 - 511

3. Riboflavin in Neurological Diseases: A Narrative Review

   • Domenico Plantone
   • Matteo Pardini
   • Giuseppe Rinaldi

   Review Article 22 April 2021 Pages: 513 - 527

4. New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and Pricing

   • Luca Pani
   • Karin Becker

   Practical Application 20 May 2021 Pages: 529 - 537

   

5. Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies

   • Francesco Giuseppe De Rosa
   • Alessandro Busca
   • Jalal A. Aram

   Original Research Article Open access 23 April 2021 Pages: 539 - 548

   

6. Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males

   • Ikumi Nakajo
   • Hiroshi Inoue
   • Masanari Shiramoto

   Original Research Article 28 April 2021 Pages: 549 - 555

   

7. Evaluation of the Pharmacokinetic Interaction and Safety of Atogepant Co-Administered with Acetaminophen or Naproxen in Healthy Participants: A Randomized Trial

   • Ramesh Boinpally
   • John Spaventa
   • Matthew Butler

   Original Research Article Open access 05 May 2021 Pages: 557 - 567

   

8. Cost-effectiveness Analysis of Trastuzumab Emtansine as Second-line Therapy for HER2-Positive Breast Cancer in China

   • Huahua Zhang
   • Yandong Zhang
   • Jiangfeng Wang

   Original Research Article 20 April 2021 Pages: 569 - 577

   

9. Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials

   • Christy Cappelletti
   • Andrea Maes
   • Colin Reisner

   Original Research Article Open access 04 June 2021 Pages: 579 - 590

   

10. Correction to: Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use

    • Sheridan M. Hoy

    Correction Open access 20 April 2021 Pages: 591 - 591

11. Correction to: Decision Analysis: Omadacycline Relative to Moxifoxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difcile Infection

    • Thomas P. Lodise
    • Rohit Mistry
    • Kenneth LaPensee

    Correction Open access 28 April 2021 Pages: 593 - 593